CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, C.
Right arrow Articles by Sugimura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, C.
Right arrow Articles by Sugimura, H.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 29-34, January 2002
© 2002 American Association for Cancer Research

Interaction between Cytochrome P-450 2E1 Polymorphisms and Environmental Factors with Risk of Esophageal and Stomach Cancers in Chinese1

Changming Gao, Toshiro Takezaki, Jianzhong Wu, Zhongyou Li, Jiandong Wang, Jianhua Ding, Yanting Liu, Xu Hu, Tianliang Xu, Kazuo Tajima and Haruhiko Sugimura2

Division of Epidemiology, Cancer Research Institute of Jiangsu Province, Nanjing 210009, China [C. G., J. W., J. D., Y. L.]; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan [T. T., K. T.]; First Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan [Z. L., J. W., H. S.]; and Public Health Center of Huaian City, Huaian 221300, China [X. H., T. X.]

Because cytochrome P-450 2E1 (CYP2E1) is involved in metabolic activation of environmental chemical carcinogens, gene polymorphisms that alter its functions may be associated with cancer susceptibility. However, previous studies have revealed disconcordant results with regard to cancer risk. To investigate gene-environment interactions with the RsaI polymorphism of CYP2E1 in terms of risk of esophageal and stomach cancers, we conducted a case-control study with 93 esophageal and 98 stomach cancer cases and 196 population-based controls in a high-endemic area for these cancers of China. We assayed genomic DNA samples for RFLPs in the CYP2E1 by PCR amplification, followed by digestion with RsaI, and collected information on environmental factors by a questionnaire approach. Odds ratios were estimated with an unconditional logistic model, after adjustment for potential confounding factors. The proportional distribution of the homozygous common RsaI alleles did not differ between cancer cases of the esophagus (59.1%) and stomach (59.2%), and controls (61.7%). However, we found a significant positive interaction between the heterozygous and homozygous RsaI rare alleles and ever-smoking in the odds ratio for stomach cancer (P = 0.015). The interaction between the gene polymorphism and dietary factors, such as garlic consumption, was not observed in both cancer cases. These results suggest that gene-environment interactions between the CYP2E1 polymorphism and smoking may have the potential to alter the susceptibility for cancer development in the stomach.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Rossini, D.C.M. Rapozo, S.C. Soares Lima, D.P. Guimaraes, M.A. Ferreira, R. Teixeira, C.D.P. Kruel, S.G.S. Barros, N.A. Andreollo, R. Acatauassu, et al.
Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population
Carcinogenesis, December 1, 2007; 28(12): 2537 - 2542.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Boccia, A. D. Lauretis, F. Gianfagna, C. M.v. Duijn, and G. Ricciardi
CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: a meta-analysis of the literature
Carcinogenesis, January 1, 2007; 28(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Milner
Preclinical Perspectives on Garlic and Cancer
J. Nutr., March 1, 2006; 136(3): 827S - 831S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W.-c. You, J.-Y. Hong, L. Zhang, K.-f. Pan, D. Pee, J.-y. Li, J.-l. Ma, N. Rothman, N. Caporaso, J. F. Fraumeni Jr., et al.
Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 451 - 458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.